What did @lovemelbon actually say?
The creator pitched what they called the "ultimate anti-aging peptide sex" stack, naming GHK-Cu for skin elasticity and wrinkles, BPC-157 for joint pain, inflammation, and muscle recovery, and a tie between MOTS-c and NAD+ for cellular energy and making the body "run younger from the inside out." They wrapped with a disclaimer that none of it is medical advice, then linked to vendors and discount codes in their bio.
That last part matters. Recommending specific vendors and discount codes while claiming educational intent is a gray area that regulators have been scrutinizing more aggressively since 2023. The "not medical advice" tag does not neutralize commercial influence when a purchase funnel is attached to the content.
Does the science back this up?
Partially, but the evidence ladder varies wildly between these compounds, and the video treats them as equally proven when they are not.
GHK-Cu has the strongest topical skin data. Pickart and Margolina (2018, Cosmetics) reviewed decades of research showing GHK-Cu stimulates collagen synthesis, activates antioxidant systems, and reduces inflammatory signaling in human fibroblasts. Most of that work is in vitro or on topical formulations, not injected peptides, which is a distinction the video skips entirely.
BPC-157 has promising animal data. Seiwerth et al. (2014, Current Pharmaceutical Design) documented accelerated tendon and muscle healing in rodent models, with effects on nitric oxide pathways. Human clinical trials are essentially nonexistent as of 2024, which is a significant gap for a compound being sold as a recovery solution.
MOTS-c is interesting and early-stage. Lee et al. (2015, Cell Metabolism) identified it as a mitochondrial-derived peptide that improves insulin sensitivity in mice. Human data is thin. NAD+ precursors like NMN and NR have more human research behind them, though "NAD+" itself is not well-absorbed orally, making the framing imprecise.
What did they get wrong (or right)?
They got the general mechanism descriptions in the right neighborhood, but oversold certainty across the board.
Saying GHK-Cu "literally helps to smooth and tighten the skin" is defensible for topical use but misleads viewers into thinking systemic peptide injections produce the same effect. The delivery method changes the equation significantly.
Calling BPC-157 "perfect for joint pain" is an overreach. Animal models are not human clinical trials. The FDA issued a notice in 2023 identifying BPC-157 as a substance that raises safety concerns, and it is not approved for any human indication. Calling it "perfect" ignores that entirely.
The MOTS-c mention is probably the most unsupported claim here. Describing it as something that helps the body "run younger from the inside out" is marketing language dressed up as biology. Lee et al.'s mouse data is real, but the leap to human anti-aging application is not established.
Credit where it is due: recommending professional consultation is correct, even if burying it under a vendor link undercuts its sincerity.
What should you actually know?
These peptides are not equivalent in their evidence base, and none of them have FDA approval for the uses described in this video.
GHK-Cu is the most studied for cosmetic purposes, with legitimate dermatology literature behind topical applications. If you are interested in it, the topical versus injectable distinction matters and should be a conversation with a licensed provider, not a decision driven by a discount code.
BPC-157 carries real regulatory risk. The FDA's 2023 guidance explicitly flagged it as a compound of concern. Compounding pharmacies can still produce it in some contexts, but the landscape is shifting and anyone sourcing it from unverified vendors is taking on unknown quality and safety risks.
NAD+ precursors like NMN have actual human pilot data. Yoshino et al. (2021, Science) found metabolic improvements in postmenopausal women supplementing with NMN. That is meaningful, even if it is not the same as anti-aging proof. Saying "NAD+" without specifying the precursor or delivery method is imprecise in a way that matters clinically.
If you want to explore peptide therapy, a regulated telehealth provider who reviews your bloodwork and health history is the appropriate starting point, not a TikTok vendor link.